TTRXTurn Therapeutics Inc. Common Stock
9.460USD-3.67%Mkt Cap: 287.28M $P/E: —3d ago
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic thro…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap287.28M $
Enterprise Value280.01M $
Revenue (TTM)—
Gross Profit-1.61M $
Net Income (TTM)-3.19M $
Revenue/Share—
Last Price9.460 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-63.60
PEG—
EV/EBITDA-32.92
EV/Revenue—
P/S—
P/B46.54
EPS (TTM)-0.27
EPS (Forward)-0.15
52W Range
2.57029% of range26.50
52W High26.50 USD
52W Low2.570 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-68.15%
ROA-26.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.56M $
CapEx (TTM)152.99K $
FCF Margin—
FCF Yield1.45%
Net Debt-4.17M $
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity0.02
Current Ratio1.19
Quick Ratio1.17
Book Value/Sh0.2050 USD
Cash/Share0.3450 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.00 USD
Upside (mean)+174.8%
Target Range26.00 USD – 26.00 USD
# Analysts1
Ownership
Shares Out.30.37M
Float10.83M
Insiders52.85%
Institutions3.79%
Short Interest
Short Ratio0.7d
Short % Out.0.28%
Shares Short57.73K
Short (prev mo.)38.51K
Technical
SMA 508.352 (+13.3%)
SMA 2005.001 (+89.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)84.07K
Avg Vol (10d)53.10K
Technical Indicators
RSI (14)52.8
MACD0.4419
MACD Signal0.5035
MACD Hist.-0.0617
BB Upper11.05 USD
BB Middle9.216 USD
BB Lower7.384 USD
BB Width39.77%
ATR (14)0.8118 USD
Vol Ratio (20d)0.36x